Fundación MEDINA collaborates with its metabolomics platform in the DE R&D project on liquid biopsy in prostate cancer, led by the Recoletas Campo Grande Hospital, in alliance with IBSAL (Biomedical Research Institute of Salamanca) and Atrys Health, through which...
News Archive
Fundación MEDINA, DNDi and Institut Pasteur Korea announce new funding from “la Caixa” Health Research for research partnership to discover new natural products against leishmaniasis and Chagas disease
Granada, Spain September 28th 2020 Fundación MEDINA, DNDi and Institut Pasteur Korea announce new funding from “la Caixa” Health Research for research partnership to discover new natural products against leishmaniasis and Chagas disease Fundación MEDINA, the Drugs for...
MEDINA, Almirall and UC3M to research new treatments for rare genetic diseases
Granada: 28 May 2020 MEDINA, Almirall and UC3M to research new treatments for rare genetic diseases. Fundación MEDINA, Almirall, S.A. (ALM) and the University Carlos III Madrid (UC3M) have launched a project to find new treatments for recessive dystrophic...
MEDINA joins the global COVID-19 research effort looking for new therapeutics and diagnostic solutions for SARS-CoV-2.
MEDINA is a drug discovery organization and a partner site of the European research infrastructure EU-OPENSCREEN (www.eu-openscreen.eu). Leveraging our drug discovery expertise, the potential of our natural product libraries and the high throughput screening and...
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
New article by Fundacion MEDINA in collaboration with the Department of Oncology at the Ludwig Institute for Cancer Research of the University of Lausanne, the Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM) of the...
First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species.
New article by Fundacion MEDINA in collaboration with the Marine Biotechnology Department at the Stazione Zoologica Anton Dohrn, Naples, and the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm) of the University of Messina:...
BSP meeting Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research. March 8 – 11, Granada- Spain.
Dr. Freddie Annang, a specialist in drug discovery against parasitic diseases from Fundación MEDINA, attended the BSP meeting entitled “Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research” which took place in Granada from the...
Determination of a group of biomarkers through metabolomics studies that could be a “fingerprint” to diagnose metastatic colon cancer.
Colorectal cancer is one of the main causes of cancer death worldwide, and novel biomarkers are urgently needed for its early diagnosis and treatment. The utilization of metabolomics to identify and quantify metabolites in body fluids may allow the detection of...
V GQB Chembio Group Meeting, February 19-21, Granada- Spain.
Fernando Reyes and Ignacio Pérez-Victoria, from the Chemistry Department of MEDINA, attended the V GQB Chembio Group Meeting celebrated in Granada from the 19th to the 21st of February. Both presented recent results on the combined use of...
LISSA Project: Alternatives to the use of disinfectants in the food industry aimed at reducing the survival of Listeria monocytogenes and Salmonella enterica on surfaces.
Fundación MEDINA participates in the LISSA project, Alternatives to the use of disinfectants in the food industry aimed at reducing the survival of Listeria monocytogenes and Salmonella enterica on the surfaces, coordinated by Dr. Joaquín Venancio Martínez Suárez of...